The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform for point-of-need testing. Accellix instruments and assays will be used…
GE HealthCare (Nasdaq: GEHC) has announced the 510(k) submission for CleaRecon DL, a deep learning technology aimed at enhancing the quality of cone-beam computed tomography (CBCT) images. This AI-powered 3D reconstruction technology is designed for use in the interventional suite…
Lightbeam Health Solutions, a leader in population health technology, Primary Partners, a Florida-based organization of over 750 independent physicians, and Alliance for Community Health (AFCH), a Florida nonprofit, have been honored with the 2024 SDOH Points of Light recognition by…
Aventa™ Genomics, LLC, a clinical laboratory specializing in 3D genomics to enhance patient outcomes and a wholly-owned subsidiary of Arima Genomics, Inc., announced today that it has received a favorable final pricing decision for the 2025 Centers for Medicare and…
Jack Nathan Medical Corp. (TSXV: “JNH”; OTCQB: “JNHMF”) has successfully completed the sale of its Canadian business to WELL Health Technologies Corp. (WELL), as part of a strategic shift in its operations. The deal, valued at Cdn$5,000,000, also resulted in…
Janux Therapeutics, Inc. (Nasdaq: JANX), a clinical-stage biopharmaceutical company developing innovative immunotherapies, announced positive interim clinical data for its JANX007 program in metastatic castration-resistant prostate cancer (mCRPC). The company will host a virtual event today at 4:30 PM ET to…
Radiology Partners (RP), the leading radiology practice in the U.S., and RADPAIR, a leader in generative AI-driven radiology solutions, have announced a strategic partnership aimed at advancing innovation in radiology and tackling critical capacity challenges. The collaboration will focus on…
Hologic, Inc. (Nasdaq: HOLX) presented new research at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), showcasing the performance of its Genius AI® Detection 2.0 software across diverse patient populations. Artificial intelligence (AI)…
Mission Bio, a leader in single-cell multiomics for precision medicine, has announced a collaboration with Dr. C. Ola Landgren, MD, PhD, director of a renowned myeloma research laboratory. Dr. Landgren, along with Dr. David Coffey and Dr. Benjamin Diamond from…
Stallergenes Greer, a biopharmaceutical company specializing in allergen immunotherapy (AIT), has announced a significant milestone with the positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA). The recommendation is for the…